Exscalate4CoV Overview
- Website
- exscalate4cov.eu
- Industry
- Biotechnology Research
- Employees
- 351
- Founded
- 2020
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Exscalate4CoV
E4C is a public-private consortium supported by the European Commission’s Horizon 2020 tender for projects to counter the Coronavirus pandemic and improve the management and care of patients. At the core of E4C is Exscalate (EXaSCale smArt pLatform Against paThogEns), at present the most powerful and cost-efficient intelligent supercomputing platform in the world. Exscalate has a "chemical library" of 500 billion molecules and a processing capacity of more than 3 million molecules per second. The E4C consortium, coordinated by Dompé farmaceutici, is composed by 18 members from seven European countries.
Compare Similar Companies to Exscalate4CoV
The Estée Lauder Companies Inc.
Personal Care Product Manufacturing
MENARINI Group
Pharmaceutical Manufacturing
Zambon
Pharmaceutical Manufacturing
Alfasigma
Pharmaceutical Manufacturing
Angelini Pharma
Pharmaceutical Manufacturing
Fidia Pharma
Pharmaceutical Manufacturing
Dompé
Pharmaceutical Manufacturing
IBSA Italy
Pharmaceutical Manufacturing
DIESSE Diagnostica Senese S.p.A.
Biotechnology Research
Zentiva Italia
Pharmaceutical Manufacturing